These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16088195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
    Kim YJ, Park H, Lee HY, Ahn YM, Ha EH, Suh SH, Pang MG.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):47-52. PubMed ID: 16949193
    [Abstract] [Full Text] [Related]

  • 5. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
    Sozer V, Himmetoglu S, Korkmaz GG, Kaya S, Aydin S, Yumuk V, Hatemi H, Uzun H.
    Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
    [Abstract] [Full Text] [Related]

  • 6. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL, Li M, Zhou JG, Yang QB, Du LJ, Du J.
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [Abstract] [Full Text] [Related]

  • 7. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA, Hassanien MA, Ibrahim EA, El-Noeman Sel-D.
    J Diabetes Complications; 2010 Nov; 24(5):325-33. PubMed ID: 19553142
    [Abstract] [Full Text] [Related]

  • 8. Relationship among plasma secretory phospholipase A2, oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors.
    Konukoglu D, Firtina S, Serin O, Cavusoglu C.
    Indian J Med Res; 2009 Apr; 129(4):390-4. PubMed ID: 19535833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O, Konukoglu D, Firtina S, Mavis O.
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [Abstract] [Full Text] [Related]

  • 12. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT, van Tits BJ, Hak-Lemmers HL, Roes EM, Steegers EA, Peters WH.
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z.
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
    Yaghmaei M, Hashemi M, Azarian A, Moazeni-Roodi A, Mokhtari M, Naghavai A, Salimi S, Mohammadi M, Taheri M, Ghavami S.
    Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
    [Abstract] [Full Text] [Related]

  • 18. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.
    Acta Biochim Pol; 2006 May; 53(4):783-7. PubMed ID: 17106515
    [Abstract] [Full Text] [Related]

  • 19. A case-control study of oxidized low density lipoproteins and preeclampsia risk.
    Sanchez SE, Williams MA, Muy-Rivera M, Qiu C, Vadachkoria S, Bazul V.
    Gynecol Endocrinol; 2005 Oct; 21(4):193-9. PubMed ID: 16316839
    [Abstract] [Full Text] [Related]

  • 20. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S.
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.